Kategori:Banbrytande terapi
Sidor i kategorin "Banbrytande terapi"
A
Abemaciclib
Adagrasib
Aflibercept
Alectinib
Allopregnanolon
Amikacin
Amivantamab
Asciminib
Asfotas alfa
Atezolizumab
Atoltivimab/maftivimab/odesivimab
Avalglucosidas alfa
Avapritinib
Avelumab
Axicabtagene ciloleucel
Azacitidin
B
Balovaptan
Banbrytande terapi
Baricitinib
Belantamab mafodotin
Belumosudil
Belzutifan
Betibeglogene autotemcel
Blinatumomab
Brentuximab vedotin
Brexucabtagene autoleucel
Burosumab
C
C-Met-hämmare
Cabotegravir
Cabozantinib
Canakinumab
Capmatinib
Cemiplimab
Ceritinib
Cerliponas alfa
Ciltacabtagene autoleucel
Crizanlizumab
Crizotinib
D
Dapagliflozin
Daratumumab
Dostarlimab
Dupilumab
Durvalumab
E
Ebolavaccin
Elbasvir/grazoprevir
Elexacaftor
Elexacaftor/tezacaftor/ivacaftor
Elivaldogene autotemcel
Elotuzumab
Eltrombopag
Emapalumab
Emicizumab
Enfortumab vedotin
Entrectinib
Erdafitinib
Esketamin
Etranacogene dezaparvovec
Evinacumab
F
Fekal mikrobiota
Fosdenopterin
Fostemsavir
G
Galcanezumab
Givosiran
I
Ibalizumab
Ibrutinib
Idarucizumab
Idecabtagene vicleucel
Idelalisib
Ivacaftor
L
Lanadelumab
Lecanemab
Ledipasvir
Ledipasvir/sofosbuvir
Lenacapavir
Lenvatinib
Lisocabtagene maraleucel
Lista över läkemedel som beviljats banbrytande terapibeteckning
Lonafarnib
Lumacaftor/ivacaftor
Lumasiran
Lutetium (177Lu) vipivotid tetraxetan
M
Maribavir
Mitomycin C
Mobocertinib
Mosunetuzumab
N
Nadofaragene firadenovec
Naxitamab
Nintedanib
Niraparib
Nirogacestat
Nivolumab
O
Obinutuzumab
Ocrelizumab
Ofatumumab
Olaratumab
Ombitasvir
Ombitasvir/paritaprevir/ritonavir
Onasemnogen abeparvovec
Osimertinib
P
Palbociclib
Paritaprevir
Pembrolizumab
Pemigatinib
Pexidartinib
Pimavanserin
Pirfenidon
Pneumokockkonjugatvaccin
Polatuzumab vedotin
Pralsetinib
R
RVSV-ZEBOV-vaccin
Ranibizumab
Regenerativ medicin avancerad terapi
Rindopepimut
Ripretinib
Ritonavir
Rucaparib
S
Sacituzumab govitecan
Scioderm
Sebelipase alfa
Selpercatinib
Selumetinib
Setmelanotid
Sirolimus
Sofosbuvir
Sofosbuvir/velpatasvir
Sotorasib
Spesolimab
Sutimlimab
T
Tabelecleucel
Tafamidis
Tafenokin
Tebentafusp
Teclistamab
Teplizumab
Tepotinib
Teprotumumab
Tezepelumab
Tisagenlecleucel
Trastuzumab deruxtecan
Trilaciclib
Tucatinib
U
Umbralisib
Uridintriacetat
V
Valoktokogen roxaparvovec
Venetoclax
Voxelotor
Z
Zanubrutinib